8 December 2022
Aukett Swanke Group Plc
("Aukett Swanke", the "Company", or, together with its subsidiaries, the "Group")
Board Changes
Aukett Swanke Group Plc is pleased to announce the following board changes:
Group Chief Executive Officer
As announced on 30 March 2022, Nicholas Thompson, who has been a director of the Group for 28 years, of which 17 years have been as Group Chief Executive Officer, will retire as Chief Executive Officer and stand down from the Board on 31 December 2022.
From 1 January 2023, Robert Fry, currently an Executive Director on the Board and the Managing Director of the Group's international businesses, will become Chief Executive Officer. Robert has 35 years' experience in the industry, with 17 years at executive level, and has been with the Group for the past nine years.
Non-Executive Chairman
The Group is also pleased to announce that Clive Carver, who has been an independent non-executive director since May 2019, has been appointed Independent Non-Executive Chairman with immediate effect. Raul Curiel, who has been Non-Executive Chairman for the past three and a half years will remain on the Board as a non-executive director.
For further information please contact:
| Aukett Swanke Group Plc | |
| Nicholas Thompson, Antony Barkwith | +44 (0) 20 7843 3000
|
| | |
| Strand Hanson Limited (Financial and Nominated Adviser) | |
| James Bellman, Richard Johnson | +44 (0) 20 7409 3494 |
| | |
| Arden Partners plc (Broker) | |
| John Llewellyn-Lloyd, Louisa Waddell | +44 (0) 20 7614 5900 |
| | |
| Investor/Media | |
| Chris Steele | +44 (0) 7979 604 687 |
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.